Cargando…
Impact of Hepatocyte Growth Factor on Skeletal Myoblast Transplantation Late After Myocardial Infarction
In clinical studies, skeletal myoblast (SKMB) transplantation late after myocardial infarction (MI) has minimal impact on left ventricular (LV) function. This may be related to our previous observation that the extent of SKMB engraftment is minimal in chronic MI when compared to acute MI, which corr...
Autores principales: | O’Blenes, Stacy B., Li, Audrey W., Bowen, Chris, DeBay, Drew, Althobaiti, Mohammed, Clarke, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653889/ https://www.ncbi.nlm.nih.gov/pubmed/23700363 http://dx.doi.org/10.4137/DTI.S11802 |
Ejemplares similares
-
The Na(+)/Ca(2+) exchange inhibitor SEA0400 limits intracellular Ca(2+) accumulation and improves recovery of ventricular function when added to cardioplegia
por: Egar, Jeanne, et al.
Publicado: (2014) -
Identification of apoptosis-related microRNAs and their target genes in myocardial infarction post-transplantation with skeletal myoblasts
por: Liu, Qi, et al.
Publicado: (2015) -
Development of a Rat Clinical Frailty Index
por: Yorke, Amy, et al.
Publicado: (2017) -
Transplantation of HGF gene-engineered skeletal myoblasts improve infarction recovery in a rat myocardial ischemia model
por: Rong, Shu-Ling, et al.
Publicado: (2017) -
Correction: Transplantation of HGF gene-engineered skeletal myoblasts improve infarction recovery in a rat myocardial ischemia model
por: Rong, Shu-Ling, et al.
Publicado: (2018)